Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
Secerna Website Images Boost Startup Success With IP Rights
European, Industry news 01/11/2023

Boost Startup Success with IP Rights: New Study Reveals Insights

Secerna Website Images 2023 (16)
European, News 23/10/2023

Protecting Smart Health Wearable Innovations with Intellectual Property

IP Career
News 16/10/2023

A Rewarding Career at the Forefront of Innovation

Secerna Website Images 2023 (10)
News 13/10/2023

Secerna to exhibit at Newcastle University's Graduate Recruitment and Placements Fair

EPO
European, News 29/09/2023

Urgent Reminder: Abolition of the EPO's "10-Day Rule" on November 1st 2023

Secerna Website Images 2023 (8)
European, News 27/09/2023

EU Intellectual Property Legislation for Industrial Designs to be Modernised

AI
European, News 13/09/2023

Protecting AI-Enhanced Medical Technologies in Europe

Secerna Website Images 2023 (5)
European, Industry news, News 08/09/2023

UK Rejoins EU's Horizon Europe Scientific Research Programme

Huw And Niamh
Events, News 08/09/2023

Secerna to attend BioYorkshire: Activating the bioeconomy

12 13 14 15 16 17 18 19 20 21 22